Filing Details
- Accession Number:
- 0001062993-25-002706
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-18 16:49:57
- Reporting Period:
- 2025-02-14
- Filing Date:
- 2025-02-18
- Accepted Time:
- 2025-02-18 16:49:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2055523 | E. Amy Herr | 614 Mckinley Place Ne Minneapolis MN 55413 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-02-14 | 1,976 | $44.33 | 3,836 | No | 4 | M | Indirect | By significant other |
Common Stock | Disposition | 2025-02-14 | 1,860 | $65.96 | 1,976 | No | 4 | S | Indirect | By significant other |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | By significant other |
No | 4 | S | Indirect | By significant other |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2025-02-14 | 1,976 | $0.00 | 3,256 | $44.33 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,280 | 2025-08-08 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,040 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $72.05 | 2035-02-03 | 2,415 | 2,415 | Direct | |
Common Stock | Stock Option (Right to Buy) | $47.60 | 2026-08-07 | 6,636 | 6,636 | Indirect | |
Common Stock | Stock Option (Right to Buy) | $66.97 | 2027-08-05 | 4,472 | 4,472 | Indirect | |
Common Stock | Stock Option (Right to Buy) | $120.46 | 2028-08-06 | 2,076 | 2,076 | Indirect | |
Common Stock | Stock Option (Right to Buy) | $94.52 | 2029-08-15 | 2,104 | 2,104 | Indirect | |
Common Stock | Stock Option (Right to Buy) | $84.61 | 2030-08-15 | 1,084 | 1,084 | Indirect | |
Common Stock | Stock Option (Right to Buy) | $74.91 | 2034-08-15 | 1,468 | 1,468 | Indirect | |
Common Stock | Stock Option (Right to Buy) | $72.05 | 2025-02-03 | 344 | 344 | Indirect | |
Common Stock | Restricted Stock Units | $0.00 | 237 | 237 | Indirect | ||
Common Stock | Restricted Stock Units | $0.00 | 480 | 480 | Indirect | ||
Common Stock | Restricted Stock Units | $0.00 | 115 | 115 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2035-02-03 | 2,415 | 2,415 | Direct |
2026-08-07 | 6,636 | 6,636 | Indirect |
2027-08-05 | 4,472 | 4,472 | Indirect |
2028-08-06 | 2,076 | 2,076 | Indirect |
2029-08-15 | 2,104 | 2,104 | Indirect |
2030-08-15 | 1,084 | 1,084 | Indirect |
2034-08-15 | 1,468 | 1,468 | Indirect |
2025-02-03 | 344 | 344 | Indirect |
237 | 237 | Indirect | |
480 | 480 | Indirect | |
115 | 115 | Indirect |
Footnotes
- The option vests on the earlier of the one-year anniversary of the grant date or the date of Bio-Techne's annual meeting of shareholders.
- Fully vested.
- 520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and 516 shares vest on 8/6/2024.
- 528 shares vest on 8/15/2023 and 8/15/2025; 524 shares vest on 8/15/2024 and 8/15/2026.
- 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
- 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
- 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- 119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.
- 160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
- 38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.